AstraZeneca/MSD’s Koselugo Among 14 New Hopefuls At EMA
EU Filing Of Semumetinib Coincides With US Approval
Executive Summary
New drugs from Eli Lilly, Pfizer, Janssen, GSK, Arvelle, BioCryst, Diurnal and Myovant are also among the latest products the European Medicines Agency is evaluating for potential pan-EU approval.